Suchergebnisse - "Wang, Menglei"

PubPharm (4)

1

Access to innovative anticancer medicines in China : a national survey on availability, price and affordability

enthalten in: BMJ open | 2024

von Li, W. | Lu, W. | Chen, H. | +7

2

Reply : Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials

enthalten in: Clinical endocrinology | 2023

von Su, J. | Fu, Y. | Wang, M. | +1

CommentOn: Clin Endocrinol (Oxf). 2021 Sep;95(3):478-488. - PMID 33834514

3

Efficacy and safety of multi-kinase inhibitors in patients with radioiodine-refractory differentiated thyroid cancer : a systematic review and meta-analysis of clinical trials

enthalten in: Expert review of anticancer therapy | 2022

von Su, J. | Wang, M. | Fu, Y. | +9

4

Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy

enthalten in: ACS applied materials & interfaces | 2020

von Wang, M. | Yang, Q. | Li, M. | +10

1
[1]